News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 13, 2015

Communicating With Your Healthcare Team

Episodes in this series

EP. 1 Importance of Breast Cancer Screening

EP. 1 Importance of Breast Cancer Screening

EP. 2 Breast Cancer in the Media

EP. 2 Breast Cancer in the Media

EP. 3 Breast Cancer: The 3 Receptors and Treatment

EP. 3 Breast Cancer: The 3 Receptors and Treatment

EP. 4 Breast Cancer Treatment

EP. 4 Breast Cancer Treatment

EP. 5 The Importance of Your Care Team

EP. 5 The Importance of Your Care Team

EP. 6 Communicating With Your Healthcare Team

EP. 6 Communicating With Your Healthcare Team

EP. 7 Breast Cancer: Top Tips for Support

EP. 7 Breast Cancer: Top Tips for Support

EP. 8 Breast Cancer: A Patient's Story

EP. 8 Breast Cancer: A Patient's Story

EP. 9 Breast Cancer: Breaking the News of Cancer

EP. 9 Breast Cancer: Breaking the News of Cancer

EP. 10 Breast Cancer: The Role of the Caregiver

EP. 10 Breast Cancer: The Role of the Caregiver

EP. 11 How Cancer Changes You

EP. 11 How Cancer Changes You

Newsletter

Stay up to date on cancer updates, research and education

Related Content

breast cancer

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

January 30th 2026

Bonnie Annis

The Last Walk Down the Hall: Reflections Before Entering Cancer Survivorship

January 30th 2026

Dr. Brittany Dulmage explains how biotin can interfere with lab testing during cancer care: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

January 30th 2026

breast cancer

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

January 30th 2026

breast cancer

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

January 29th 2026

Trending on CURE

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

FDA Accepts Ivonescimab Application for EGFR Lung Cancer

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

Key GI Cancer Advances from the 2026 ASCO Symposium